Chinese Academy of Medical Sciences COVID-19 vaccine

From Wikipedia, the free encyclopedia

Chinese Academy of Medical Sciences COVID-19 vaccine
Vaccine description
TargetSARS-CoV-2
Vaccine typeInactivated
Clinical data
Other namesCovidful (Chinese: 科维福; pinyin: Kēwéifú)
Routes of
administration
Intramuscular
Legal status
Legal status
  • Emergency authorization: China [1]
Identifiers
CAS Number
DrugBank

Chinese Academy of Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute of Medical Biology, Chinese Academy of Medical Sciences [zh].

In May 2020, Covidful started phase I/II clinical trial with 942 participants in China.[3]

In January 2021, Covidful started phase III clinical trials with 34,020 from Brazil and Malaysia.[4]

Authorizations

References

Related Articles

Wikiwand AI